Inventors
Natalie Mount, Oxana Polyakova, Robert Good, Mark Uden, Raj Jaysukhlal Mehta, Oliver Nussbaumer
Assignees
Gamma Delta Therapeutics Ltd
Abstract
The invention relates to anti-Vδ1 antibodies or fragments thereof for use in methods of treating a cancer, an infectious disease or an inflammatory disease in a subject in need thereof.